Dr. Sherman on Screening Obstacles in Liver Cancer

Video

Morris Sherman, MD, PhD, professor of Medicine at University of Toronto, discusses the issues oncologists face with screening patients for hepatocellular carcinoma (HCC) in an interview during the 10th International Liver Cancer Association (ILCA) Annual Conference.

Morris Sherman, MD, PhD, professor of Medicine at University of Toronto, discusses the issues oncologists face with screening patients for hepatocellular carcinoma (HCC) in an interview during the 10th International Liver Cancer Association (ILCA) Annual Conference.

For years, ultrasound has been the standard screening tool for HCC, Sherman explains. However, ultrasounds themselves and identifying which patients should be screened have become two major issues in this area. Early data show that there are a multitude of risk scores that would help narrow the pool of patients who are at risk for cirrhosis, for example.

Additionally, 25% of patients with hepatitis B will go on to develop cancer; therefore, risk scores are under development that will avoid having to screen the remaining 75% of patients. However, in conducting these types of studies, researchers need to determine a threshold of risk—a factor that has not yet been determined, he adds.

<<<

View more from the 2016 International Liver Cancer Association Annual Conference

Related Videos
Ilyas Sahin, MD
Patrick I. Borgen, MD
Kari Hacker, MD, PhD, NYU Grossman School of Medicine
Janos L. Tanyi, MD, PhD, associate professor, Obstetrics and Gynecology, Hospital of the University of Pennsylvania
Reshma Lillaney Mahtani, DO
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania